This assay is intended for the in vitro qualitative measurement of Hepatitis B virus (HBV) DNA, Hepatitis C virus (HCV) RNA, and Human Immunodeficiency Virus Type 1 and 2(HIV 1 + 2) RNA in human serum or plasma samples. This assay is used for donor screening and as an auxiliary diagnosis for clinical infections of Hepatitis B virus, Hepatitis C virus and Human Immunodeficiency Virus Type 1 and 2.
Detection of 3 viruses from a single sample
One test provides 3 direct target‑specific results (HIV/HBV/HCV)
Stable at 2‑8°C
Helping reduce storage and transport requirements
Flexible automation options
From high‑throughput platforms to low‑throughput systems
Dual contamination control
dUTP/UNG enzyme system + mineral oil overlay
| Parameter | Specification Details |
|---|---|
| Analyte | HBV DNA, HCV RNA, HIV (1+2) RNA |
| Target Regions | HIV: LTR and polHBV: S and preC/CHCV: 5'UTR |
| Limit of Detection (LOD) | HBV DNA: 5 IU/mLHCV RNA: 10 IU/mLHIV‑1/2 RNA: 50 IU/mL |
| Sample Type | Plasma / Serum |
| Storage | 2‑8℃ |
| Shelf Life | 12 Months |
Catalog. No. | Product Name | Spec. | Certificate |
M1051 | Molvizon HIV1&2/HBV/HCV | 96 Tests/Kit | NMPA |